Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis-Reference-Cited by-同舟云学术

Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis

Published:2022-10-04 Issue:6 Volume:66 Page:702-708
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle and Nerve

Author:

Thakore Nimish J.¹^ORCID,Lapin Brittany R.²,Mitsumoto Hiroshi³,Pooled Resource Open‐Access ALS Clinical Trials Consortium

Affiliation:

1. Neuromuscular Center, Department of Neurology Cleveland Clinic Cleveland Ohio USA

2. Neurological Institute Center for Outcomes Research and Evaluation (NICORE) and Lerner Research Institute Department of Quantitative Health Sciences Cleveland Clinic Cleveland Ohio USA

3. Department of Neurology, Division of Neuromuscular Medicine Columbia University Medical Center New York New York USA

Funder

Cleveland Clinic

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.27724

Reference29 articles.

1. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

2. Dose-ranging study of riluzole in amyotrophic lateral sclerosis

3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND);Miller RG;Cochrane Database Syst Rev,2012

4. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis

5. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data;Journal of Racial and Ethnic Health Disparities;2024-07-08

2. Continuity of treatment in ALS: Benefits and challenges of maintaining riluzole over the course of the disease;Journal of the Neurological Sciences;2024-06

3. Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS);Journal of the Neurological Sciences;2024-02

4. Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions—The CAESAR study;Pharmacoepidemiology and Drug Safety;2023-11-28

5. IMPACTO DO TRATAMENTO COM RILUZOL NA EFICIÊNCIA E REGRESSÃO DA ESCLEROSE LATERAL AMIOTRÓFICA;REVISTA FOCO;2023-11-21